Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Internal Region) Peptid
SPG20
Reaktivität: Human
Wirt: Synthetic
BP, BI
Produktnummer ABIN2457702
Kurzübersicht für Spastic Paraplegia 20 (Troyer Syndrome) (SPG20) (Internal Region) Peptid (ABIN2457702)
Target
SPG20
(Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), BioImaging (BI)
-
-
Protein-Typ
- Synthetic
-
Protein Region
- Internal Region
-
Produktmerkmale
- SPARTIN peptide is a synthetic peptide cooresponding to 15 amino acids from an internal region of SPARTIN.
-
-
-
-
Applikationshinweise
- SPARTIN Peptide is used for blocking the activity of SPARTIN antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- SPARTIN peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 ?L water, the concentration will be 0.5 mg/mL.
-
Handhabung
- When reconstituted minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C.
-
-
-
Sie sind hier:
